Stock AnalizAkso Health Group AHG
Business Services · IPO 2017 · data as of November 13, 2026
Akso Health Group (AHG) is a consumer discretionary company listed in the US with a market value of about $1.1B. In fiscal year 2026 it had revenue of $14M and net income of -$19M, a net margin of -135.0%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 51% a year, a 5-year average ROIC of -47%.
Score: 0.8 / 5
Checks passed
- Profit margin improving
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $15M | $2M | $13M | $6M | $2M | $7M | $4M | $107M | $23M |
| Net income | -$19M | -$135M | -$9M | -$1M | -$17M | -$35M | -$71M | $6M | $65M | $9M |
| Free cash flow | -$13M | $1M | — | — | -$9M | — | -$58M | -$2M | $87M | $8M |
| EPS (diluted) | $-0.02 | $-0.16 | $-0.01 | $-0.00 | $-0.02 | $-0.04 | $-0.08 | $0.01 | $0.08 | $0.01 |
| Net margin | -135.0% | -913.4% | -391.8% | -10.3% | -267.0% | -1984.5% | -1029.7% | 149.7% | 61.1% | 37.4% |
| ROIC | -10.3% | -68.0% | -4.9% | -129.2% | -21.0% | -12.3% | -55.2% | -3.9% | 46.4% | 35.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does Akso Health pay a dividend?
Not currently.
Is Akso Health a good stock to buy?
We do not give buy or sell advice. Akso Health scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.